OIRA Conclusion of EO 12866 Regulatory Review
RIN: 0936-AA08 View EO 12866 Meetings | Received Date: 11/13/2020 |
Title: Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection | |
Agency/Subagency: HHS / OIG | Stage: Final Rule |
Concluded Action: Consistent with Change | Concluded Date: 11/18/2020 |
Section 3(f)(1) Significant *: No | |
Legal Deadline: None | Economically Significant **: Yes |
Publication Date: 11/30/2020 | Unfunded Mandates: State, local, or tribal governments |
Major: Yes | Related To Homeland Security: No |
Regulatory Flexibility Analysis Required: No | Small Entities Affected: No |
Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
Pandemic Response: No | |
|